Lauren Pischel, MD
Clinical Fellow
Research & Publications
Biography
News
Coauthors
Selected Publications
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes. Chest 2020, 158:1397-1408.
- Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome.Poole AC, Pischel L, Ley C, Suh G, Goodrich JK, Haggerty TD, Ley RE, Parsonnet J. Crossover Control Study of the Effect of Personal Care Products Containing Triclosan on the Microbiome. MSphere 2016, 1.
- Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew.Rizal RE, Mediratta RP, Xie J, Kambhampati S, Hills-Evans K, Montacute T, Zhang M, Zaw C, He J, Sanchez M, Pischel L. Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew. Advances In Medical Education And Practice 2015, 6:471-7.
- Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.Raj DK, Nixon CP, Nixon CE, Dvorin JD, DiPetrillo CG, Pond-Tor S, Wu HW, Jolly G, Pischel L, Lu A, Michelow IC, Cheng L, Conteh S, McDonald EA, Absalon S, Holte SE, Friedman JF, Fried M, Duffy PE, Kurtis JD. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science (New York, N.Y.) 2014, 344:871-7.
- Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention.Ley C, Pischel L, Parsonnet J. Triclosan and triclocarban exposure and thyroid function during pregnancy-A randomized intervention. Reproductive Toxicology (Elmsford, N.Y.) 2017, 74:143-149.
- The Letter.Pischel L. The Letter. Annals Of Internal Medicine 2018, 169:126.
- Diagnosis of oesophageal mucormycosis managed with medical therapy alone.Ringer M, Pischel L, Azar MM. Diagnosis of oesophageal mucormycosis managed with medical therapy alone. BMJ Case Reports 2020, 13.
- Fast Development of High-Quality Vaccines in a Pandemic.Pischel L, Yildirim I, Omer SB. Fast Development of High-Quality Vaccines in a Pandemic. Chest 2021, 160:e1-e3.
- Bartonellosis in transplant recipients: A retrospective single center experience.Pischel L, Radcliffe C, Vilchez GA, Charifa A, Zhang XC, Grant M. Bartonellosis in transplant recipients: A retrospective single center experience. World Journal Of Transplantation 2021, 11:244-253.
- Improving diagnosis by feedback and deliberate practice: one-on-one coaching for diagnostic maturation.Sinha P, Pischel L, Sofair AN. Improving diagnosis by feedback and deliberate practice: one-on-one coaching for diagnostic maturation. Diagnosis (Berlin, Germany) 2021.
- Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.Pischel L, Walelo M, Benson J, Osborn R, Schrier R, Tuan J, Barakat L, Ogbuagu O. Race and ethnicity do not impact eligibility for remdesivir: A single-center experience. PloS One 2021, 16:e0250735.
- Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see.Pischel L, Goshua G. Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2021.
- A Brewing Back Pain.Pischel L, Geirsson A, Magaldi J, Martinello RA, Lee AI. A Brewing Back Pain. The New England Journal Of Medicine 2021, 385:66-72.